Randomized clinical trial evaluating the effect of acetazolamide on pulmonary artery pressure in women compared to men travelling to 3600 m.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
270
Administration of 1x125mg acetazolamide in the morning, 1x125mg in the evening, starting 24 hours before departure to 3600 m.
Administration of equally looking placebo capsules in the morning and in the evening, starting 24 hours before departure to 3600 m.
National Center for Cardiology and Internal Medicine
Bishkek, Gorod Bishkek, Kyrgyzstan
RECRUITINGPulmonary artery Pressure (PAP)
Sex-related difference in the altitude-induced change in RV/RA in mmHg assessed by echocardiography between acetazolamide and placebo group.
Time frame: Day 2 at 760 m and Day 2 at 3600 m
Lung comets
Sex-related difference in the altitude-induced change in ultrasound lung comets assessed by echocardiography between acetazolamide and placebo group.
Time frame: Day 2 at 760 m and Day 2 at 3600 m
Parameters of right heart function
Sex-related difference in the altitude-induced change in parameters of right heart function assessed by echocardiography between acetazolamide and placebo group.
Time frame: Day 2 at 760 m and Day 2 at 3600 m
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.